A new system for substaging pT1 papillary bladder cancer: A prognostic evaluation

Human Pathology

Volumn 36, Issue 9, 2005, Pages 981-986

  Van Der Aa, Madelon N M ^a   Van Leenders, Geert J L H ^a,b   Steyerberg, Ewout W ^a   Van Rhijn, Bas W ^a   Jöbsis, Adriaan C ^c   Zwarthoff, Ellen C ^a   Van Der Kwast, Theodorus H ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Sint Franciscus General Hospital   (Netherlands)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Bladder cancer; FGFR3 mutation; Molecular grading; Papillary urothelial cell carcinoma; pT1; Staging

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL INFILTRATION; CONTROLLED STUDY; DECISION MAKING; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; STROMA; UROTHELIUM;

AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; URINARY BLADDER NEOPLASMS;

EID: 24344501314     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.06.017     Document Type: Article

References (23)

1. J.I. Epstein, M.B. Amin, and V.R. Reuter The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee Am J Surg Pathol 22 1998 1435
2. R.T. Bryan, and D.M. Wallace "Superficial" bladder cancer-time to uncouple pT1 tumours from pTa tumours BJU Int 90 2002 846
3. W.H. Kern The grade and pathologic stage of bladder cancer Cancer 53 1984 1185
4. M.B. Amin, J.A. Gomez, and R.H. Young Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases Am J Surg Pathol 21 1997 1057
5. M.K. Parmar, L.S. Freedman, and T.B. Hargreave Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party) J Urol 142 1989 284
6. A.A. Bakkar, H. Wallerand, and F. Radvanyi FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder Cancer Res 63 2003 8108
7. C.L. Amling, J.B. Thrasher, and H.A. Frazier Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder J Urol 151 1994 31
8. G.K. Zhang, E.T. Uke, and W.C. Sharer Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder J Urol 155 1996 1907
9. Pathologists of the French Association of Urology Cancer Committee. Lamina propria microinvasion of bladder tumors, incidence on stage allocation (pTa vs pT1): recommended approach World J Urol 11 1993 161
10. M. Younes, J. Sussman, and L.D. True The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder Cancer 66 1990 543
11. MG. Bol, J.P. Baak, and S. Buhr-Wildhagen Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder J Urol 169 2003 1291
12. B.W. van Rhijn, A.N. Vis, and T.H. van der Kwast Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome J Clin Oncol 21 2003 1912
13. H. Samaratunga, D.V. Makarov, and J.I. Epstein Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression Urology 60 2002 315
14. A.N. Vis, M.A. Noordzij, and K. Fitoz Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer J Urol 164 2000 2156
15. C. Billerey, D. Chopin, and M.H. Aubriot-Lorton Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors Am J Pathol 158 2001 1955
16. D. Cappellen, C. De Oliveira, and D. Ricol Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas Nat Genet 23 1999 18
17. J.K. McKenney, J.A. Gomez, and S. Desai Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion Am J Surg Pathol 25 2001 356
18. H. Zincke, D.C. Utz, and G.M. Farrow Review of Mayo Clinic experience with carcinoma in situ Urology 26 1985 39
19. S. Holmang, H. Hedelin, and C. Anderstrom The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study J Urol 157 1997 800
20. L. Cheng, A.L. Weaver, and R.M. Neumann Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: a new proposal Cancer 86 1999 1035
21. C.E. Platz, M.B. Cohen, and M.P. Jones Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol 9 1996 1035
22. D. Sidransky, P. Frost, and A. Von Eschenbach Clonal origin of bladder cancer N Engl J Med 326 1992 737 740
23. I. Fadl-Elmula, L. Gorunova, and N. Mandahl Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding Br J Cancer 81 1999 6 12